Xiamen C&D Overview
- Founded
-
1980

- Status
-
Public
- Employees
-
26,761

- Stock Symbol
-
600153

- Investments
-
34
- Share Price
-
$1.74
- (As of Thursday Closing)
Xiamen C&D General Information
Description
Xiamen C & D Inc is a China-based modern service-oriented company mainly specializing in supply chain operation and real estate development. In regard to supply chain operation, the company has formed core business units, namely, pulp and paper, iron and steel, mineral products, agricultural products, textiles and other light industrial goods, chemical products, mechanical and electrical products, logistics services, automobiles and wines/spirits.
Contact Information
- C&D International Building
- 1699 Huandao East Road
- Xiamen, Fujian
- China
Xiamen C&D Stock Performance
(As of Thursday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$1.74 | $1.72 | $1.52 - $2.35 | $5.22B | 3.01B | 26.8M | $0.31 |
Xiamen C&D Financials Summary
In Thousands, USD |
TTM 31-Dec-2022 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
---|---|---|---|---|
EV | 27,276,497 | 27,276,497 | 25,952,224 | 16,040,532 |
Revenue | 123,662,790 | 123,662,790 | 109,623,002 | 62,668,104 |
EBITDA | 2,951,649 | 2,951,649 | 2,748,250 | 1,980,640 |
Net Income | 932,738 | 932,738 | 950,914 | 651,921 |
Total Assets | 96,350,997 | 96,350,997 | 94,516,737 | 59,361,181 |
Total Debt | 17,206,141 | 17,206,141 | 18,117,812 | 13,537,388 |
Xiamen C&D Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mao Lin | General Manager & Director | ||
Shoude Chen | Independent Director | ||
Tao Lin | Independent Director | ||
Yiyi Dai | Independent Director |
Xiamen C&D Board Members (4)
Name | Representing | Role | Since |
---|---|---|---|
0000 000 | Xiamen C&D | Chairman of Supervisory Board | 000 0000 |
0000000 00000 | Self | Vice Chairman of the Board of Directors | 000 0000 |
000000 00000 | Xiamen C&D | Chairman of the Board of Directors | 000 0000 |
Xiamen C&D Signals
Xiamen C&D Investments & Acquisitions (34)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 28-Feb-2023 | 00000 0000 | 0000 | Drug Discovery | |
0000000 000 0 | 20-Jan-2023 | 00000 0000 | 00000 | Specialty Chemicals | |
000000 000000 | 17-Jan-2023 | 00000 0000 | 00000 | Biotechnology | |
00000000 0000 | 19-Sep-2022 | 000 | 00000 | Commodity Chemicals | |
OriCell Therapeutics | 09-Jun-2022 | Later Stage VC | 00000 | Drug Discovery |
Xiamen C&D ESG
Risk Overview
Risk Rating
Updated March, 10, 2022
30.98 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.0
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,231
Rank
Percentile

Traders & Distributors
Industry
00 of 185
Rank
Percentile

Trading and Distribution
Subindustry
00 of 185
Rank
Percentile

Xiamen C&D Exits (7)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000 00000000 0000 | 30-Dec-2019 | 00000 00000 00 | 000.00 | Completed |
|
00000 0000000000 | 23-Dec-2019 | 00000 00000 00 | 000.00 | Completed |
|
000 0000000 | 17-Dec-2019 | 00000 00000 00 | 00.00 | Completed |
|
0000 00000000 0000 | 31-May-2019 | 00000 00000 00 | 000.00 | Completed |
|
CNGR Advanced Material | 31-May-2019 | Secondary Transaction - Private | 000.00 | Completed |
|